The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force

The number of available therapies for rare diseases remains low, as fewer than 6% of rare diseases have an approved treatment option. The International Rare Diseases Research Consortium (IRDiRC) set up the multi-stakeholder Data Mining and Repurposing (DMR) Task Force to examine the potential of app...

Descripción completa

Detalles Bibliográficos
Autores principales: Southall, Noel T, Natarajan, Madhusudan, Lau, Lilian Pek Lian, Jonker, Anneliene Hechtelt, Deprez, Benoît, Guilliams, Tim, Hunter, Lawrence, Rademaker, Carin MA, Hivert, Virginie, Ardigò, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Position Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794821/
https://www.ncbi.nlm.nih.gov/pubmed/31615551
http://dx.doi.org/10.1186/s13023-019-1193-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794821/
https://www.ncbi.nlm.nih.gov/pubmed/31615551
http://dx.doi.org/10.1186/s13023-019-1193-3

Ejemplares similares